Oncology Institute (TOI) Accumulated Depreciation & Amortization (2020 - 2026)

Oncology Institute (TOI) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization fell 9.42% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 9.42% YoY), and the FY2025 full-year result was $6.9 million, up 10.45% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $1.6 million, down from $6.9 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $6.9 million in Q4 2025 and bottomed at $987000.0 in Q1 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $3.2 million (2022), against an average of $3.5 million.
• The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization jumped 33.46%; it then fell 9.42% in 2026.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $4.4 million in 2022, then jumped by 33.14% to $5.9 million in 2023, then climbed by 7.05% to $6.3 million in 2024, then grew by 10.45% to $6.9 million in 2025, then sank by 76.73% to $1.6 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $1.6 million (Q1 2026), $6.9 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.

Peer Comparison